Advanced Biomed (ADVB) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Advanced Biomed (ADVB) is Moderate Underperform.

The composite score behind that read is -0.30, weighing +0.27 of bullish evidence against -0.43 bearish.

Advanced Biomed last closed at $6.34, -5.79% on the session.

Against the IVW growth benchmark the position is -6.71% over the forecast window.

The read is built from 11 underlying insights — 2 bullish and 9 bearish.

Agreement across those insights is 82%.

16 graded predictions for ADVB so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Advanced Biomed in the 99th percentile on valuation and the 95th percentile on return on equity, where 100 is best.

Advanced Biomed is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $11.12M.

StockMap tracks Advanced Biomed as the 126th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Advanced Biomed ranks 97th of 133 in the group, against a group median of -0.21.